An intermediate population, Investigational New Drug study, to provide an alternate intravenous fat nutrition, Omegaven®, to help improve liver function while providing adequate nutrition for critically ill infants with parenteral nutrition associated cholestasis
To provide Omegaven® as a compassionate treatment for critically ill infants with parenteral nutrition associated cholestasis